Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Ah Ray, you must read the AG thread in another place to know that I give my grandchildren silver coins - or have I said as much here also and it has slipped my mind? Or perhaps you post under a different handle on the AAZ thread, also in another place.
I will say that the least risky investment anyone can make is physical silver and gold in your own possession and definitely not stored in any bank.
I loved everything I read here about the science and I particularly appreciated Ananaco's explanations - he seemed to know as much as the scientists themselves. However (there's always an however, isn't there?) the time frame just kept getting moved further and further out and since I'd already had my fingers burned once in similar situation, I chose to sell.
As for me posting here, well every time I raise my head above the parapet I seem to set the cat amongst the pigeons ha ha. Not everyone liked what I had to say a few years ago, and I do believe my views about big Pharma were seen as very controversial, and it has to be said my views on cancer charities did not go down well. But thank you anyway and I sincerely wish you luck here.
mabel
Ruck,
Glad you found my post useful, though you will be aware yourself, having been in PRM that the great hopes and dreams sometimes come to nothing, with a loss to boot. Although I got out of SCLP when I was still winning, I was not boasting because I didn't make enough there to boast and I certainly had no intention of 'rubbing people's noses in it', as I think Chelsea suggested.
Hope this turns out well for all. Good luck.
mabel
Chelsea,
Have just seen this post of yours as I was away all day yesterday soon after posting, and I just casually glanced through the posts since mine. First of all, it sounds as though you are well and active, so that is good.
My posts re Martin Diggle. I have no axe to grind re Martin Diggle, it was merely an observation. It is possibly more than 15 years since I was in PRM, and come to think of it, they went far beyond £1.20 as I posted yesterday, in fact they went beyond £2.
I would not describe him as a ramper, and I am sorry my post was interpreted in that way. He was obviously a big investor, or his fund was. He was not out of order in any way in the way he posted, and what I was saying was simply, just because someone of his influence (for want of a better word) is involved, it does not necessarily mean the share will do well.
Why have I posted at this time? Well, SCLP is still on my monitor so the share price does not escape my attention and very occasionally, as yesterday, I take a look in here, sometimes even to see if you are still posting. I genuinely sympathise with loyal share holders whose dreams of this company making them rich might not materialise and felt inclined to offer a word of caution. No ulterior motive. - just be careful not to make the mistake I made in falling in love with a share.
Hope this explanation helps.
mabel
Ray,
"Why did Proteome fail?" Well, I have to admit I relied on the explanation of the science by those more knowledgeable than I am. - a bit like here really, but ultimately I think the management of the company is accountable. The conditions that PRM was going to address were innumerable, but it never quite materialised. There was always an explanation forthcoming which sounded reasonable, and I watched like a rabbit in the headlights as the share price dropped and dropped. The rest is history.
I have no doubt that the products both PRM and SCLP have to offer are good products, but there are always obstacles and hurdles thrown in by way of big Pharma to stop a small biotech from taking away a lucrative earner. Profits are made by TREATING cancer, not CURING it.
I am distrustful of the pharmaceutical industry to provide a level playing field for the benefit of those who are ill, if whatever is going to affect their bottom line. Not a scientific explanation Ray, but my own honest one.
mabel
I was invested for many years in Proteome, and Martin Diggle was a regular poster on the ad fvn thread. I soaked up the enthusiasm for that particular biotech, and what the company was going to achieve. It was mind blowing, but it was all jam tomorrow. The share price was about 120p as I remember at its height and is now a little less than 2.5p and I certainly lost money there. Not as much as some however, some of PRM's investors lost everything including their homes.
I experienced similar enthusiasm here at Scancell but fortunately saw the writing on the wall while I was still winning. Now, I would be very reluctant to invest in another biotech no matter what they were promising, and I see the same pattern happening here as happened to PRM with a constant drip, drip, drip down until it is little more than a penny. I would suggest Martin Diggle's involvement might not be as exciting as some think.
mabel
Torquay,
Thank you for your response.
I have no good thoughts, when it comes to big Pharma, the money is made from TREATING the disease, and that amounts to vast sums, so yes, the long delay in FDA approval probably can be explained there Similarly, the cancer charities, and I took a great deal of flak in that area if I remember rightly, but they can only exist if there is a problem.
Why else are the natural cures - which do exist - not exploited. The reason being that more money is to be made elsewhere. Natural things, like herbs, can't be patented in their natural form.
It doesn't take too much digging to discover just what is to be lost if cheap natural methods were found to be more effective than chemotherapy, for example, which is in itself carcinogenic. Think hospital therapy departments and the millions that is invested there - staff, equipment, whole departments. It is simply not in their interests to pursue anything other. It would be like turkeys voting for an early xmas.
I could go on, but I won't because my intention is not to disrupt and set people's teeth on edge !
mabel
I look in here, very occasionally these days, to see what the general mood is as the share price continues to move south.
Scancell reminds me so much of PRM where I was invested for several years - a company that held so much promise with it's innovative approach to the dreaded cancer, along with several other conditions including dementia.
The possibilities were so great. Lives were going to be changed and fortunes made.
Instead, fortunes were lost, especially by some of its most enthusiastic investors, who were not without scientific knowledge and had done vast amounts of research. There was always an explanation for why some particular expectation had not materialised. It was usually nothing to do with the quality of the science, but something beyond the Company's control, and I went along with this for some time, taking the opportunity to buy in at a better price. I lost money.
When SCLP came along I was similarly excited, as this time it was different. No need to elaborate, but it seems it is no different at all. I had the good sense to learn from my experience with PRM and fortunately I got out while I was still in profit.
Biotech seems to be a very risky area for investors and I now keep well away. PRM went to about £1.50 at one point and it is now about 3p. Scancell has done something similar.
I hope your share recovers and the science proves to be the great saviour of lives that we dream of, but be wary.
Good luck all.
mabel
Hello Chelsea,
Sorry to hear you are struggling with yet more health problems and wish you well in that respect.
I'm not thinking about getting back into SCLP or any other biotech, if I am honest. Had my fingers burned with PRM.
In fact I am keeping out of the stock market altogether. I just have a few 'bottom draw' shares, some of which, if they come good, will be a bonus!!
Actually, one of these, AAZ (gold miner) is doing very well and I have great hopes for the future with that one. The AAZ board in another place is the best board on that forum and is moderated very sensibly.
I think gold and silver are the things to be buying right now, but only in physical form, and stored independently, never in a bank or with the supplier. It costs more to dig an ounce of silver out of the ground than to buy a one ounce silver coin.
Silver coins are what I give my grandchildren as presents.
I'm sure the people here don't want to be subject to my views anyway, so I'll leave it there.
Good luck Chelsea, both with your health and investment.
mabel
Just thought I would look in here to see who is still invested, and to see how Chelsea is faring. Hope your health is a little better these days Chelsea - you must be doing some things right.
I can't believe that having bought in June 2012 for 10.6p and added at various times, including a chunk at 49p just a year later, the share price of SCLP is now at 8.25p.
I had 60K shares at one time, but sold my last lot sometime in 2015 and if memory serves me right, I think at around 25p or 26p because I thought the stock market was going to head south. Well, it seems the stock market didn't head south, but SCLP sure did, and with it, no doubt the hopes and dreams of many who were convinced this was going to the moon. I thought so myself for a long time.
I am reminded of another one of these biotech companies I had great hopes for, Proteome Science (PRM), whose performance failed dismally to live up to all the hype. My god, some people lost their houses with that one and these were people who had done their research and were absolutely convinced of the science behind their investment.
I hope the future for SCLP is more assured and the benefits will be forthcoming for those in need of the technology.
mabel